The initiation and progression of pancreatic ductal adenocarcinoma through a p53 lens

被引：0
|
作者：
Hanson, Kathryn J.
Minor, Allegra C.
Flowers, Brittany M.
Kaiser, Alyssa M.
Hughes, Nicholas
Vogel, Hannes
Cong, Le
Attardi, Laura D.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 02期
关键词：
D O I：
10.1158/1538-7445.PANCA2023-C056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C056
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
    Koustoulidou, S.
    Knight, J. C.
    Kersemans, V.
    O'Neill, E.
    Cornelissen, B.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S230 - S230
  • [2] The role of p53 in the development of pancreatic ductal adenocarcinoma.
    Hanson, Kathryn J.
    Flowers, Brittany M.
    Hughes, Nicholas
    Vogel, Hannes
    Cong, Le
    Attardi, Laura D.
    [J]. CANCER RESEARCH, 2021, 81 (22) : 58 - 58
  • [3] Mutant p53 promotes adenocarcinoma in pancreatic ductal cells
    Polireddy, Kishore
    Hendley, Audrey
    Pruski, Melissa A.
    Lafaro, Kelly
    Younes, Mamoun
    Maitra, Anirban
    McAllister, Florencia
    Iacobuzio-Donahue, Christine A.
    Dar, Wasim A.
    Bynon, John S.
    Leach, Steven D.
    Bailey, Jennifer M.
    [J]. CANCER RESEARCH, 2016, 76
  • [4] Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma
    Rall, CJN
    Yan, YX
    GraemeCook, F
    Beauchamp, R
    Yandell, DW
    Povoski, SP
    Rustgi, AK
    [J]. PANCREAS, 1996, 12 (01) : 10 - 17
  • [5] Study of p53 expression in pancreatic ductal adenocarcinoma and its relationship to survival
    Lorente Gea, L.
    Azagra de Miguel, I.
    Fernandez-Vega, I.
    Camacho-Urkaray, E.
    Maestro-Gomez, L.
    Gorostiaga Altuna, I.
    Gutierrez-Corres, F. B.
    Aguirre Anda, J.
    [J]. VIRCHOWS ARCHIV, 2017, 471 : S128 - S128
  • [6] Angiogenesis and p53 and H-ras mutations in pancreatic ductal adenocarcinoma
    Özer, E
    Özkal, S
    Karademir, S
    Sagol, Ö
    Sökmen, S
    Çoker, A
    Küpelioglu, A
    Astarcioglu, I
    [J]. ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1999, 21 (06): : 473 - 476
  • [7] GENETIC ALTERATIONS OF THE TUMORSUPPRESSOR GENES P53 AND DCC IN DUCTAL PANCREATIC ADENOCARCINOMA
    SIMON, B
    HOHNE, M
    WATZ, J
    KORTNER, G
    WEINEL, R
    ARNOLD, R
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : A451 - A451
  • [8] Ferritin heavy chain, FTH1, reduces p53 expression and contributes to pancreatic ductal adenocarcinoma progression
    Chiu, Ching-Feng
    Park, Ji Min
    Hung, Shao-Wen
    Chiu, Chien-Chao
    Chen, Hsin-An
    Huang, Ming-Te
    [J]. CANCER SCIENCE, 2021, 112 : 759 - 759
  • [9] GENOMIC P53 MUTATION IN A CHEMICALLY-INDUCED HAMSTER PANCREATIC DUCTAL ADENOCARCINOMA
    CHANG, KW
    MANGOLD, KA
    HUBCHAK, S
    LACONI, S
    SCARPELLI, DG
    [J]. CANCER RESEARCH, 1994, 54 (14) : 3878 - 3883
  • [10] Serum p53 antibodies as a prognostic marker in patients with pancreatic ductal adenocarcinoma (PDAC)
    Zhang, Xibo
    Shang, Haitao
    Li, Zhonglian
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 8376 - 8381
12345